Hypoxia Aggravates Myocardial Ischemia/Reperfusion Injury Through the Promotion of Ferroptosis via ACSL4 Lactylation
- 8 September 2025
- journal article
- research article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 18 (5) , 1132-1145
Abstract
Myocardial ischemia/reperfusion injury (MIRI) worsens ischemic damage, with ferroptosis as a key mediator of this iron-dependent cell death. Lactylation, a novel epigenetic modification, remains poorly understood in MIRI-associated ferroptosis. This study aimed to elucidate the mechanistic link between lactylation and ferroptosis in MIRI. Experimental results demonstrated that hypoxia/reoxygenation (H/R) induction combined with lactate (LA) treatment significantly enhanced the protein expression levels, lactylation status, and protein stability of acyl-CoA synthetase long-chain family member 4 (ACSL4). Site-specific analysis identified lysine 83 (K83) as the critical lactylation modification site on ACSL4. Functional studies revealed that LDHA knockdown-mediated suppression of lactate levels attenuated ferroptosis in H/R-treated cells, an effect that was reversed by ACSL4 overexpression. In vivo validation confirmed that LDHA depletion ameliorated ferroptosis-related damage and mitigated MIRI-induced cardiac dysfunction. Collectively, these findings establish that lactylation-regulated ACSL4 ferroptosis exacerbates MIRI pathogenesis, suggesting that targeting the lactylation-ACSL4 axis represents a promising therapeutic strategy for MIRI. Graphical AbstractKeywords
This publication has 39 references indexed in Scilit:
- Klf6 aggravates myocardial ischemia/reperfusion injury by activating Acsl4‐mediated ferroptosisThe Kaohsiung Journal of Medical Sciences, 2023
- Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal CancerAdvanced Science, 2023
- Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAsDrug Resistance Updates, 2023
- LDHA as a regulator of T cell fate and its mechanisms in diseaseBiomedicine & Pharmacotherapy, 2023
- Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axisBiomedicine & Pharmacotherapy, 2022
- A proteomic atlas of ligand–receptor interactions at the ovine maternal–fetal interface reveals the role of histone lactylation in uterine remodelingJournal of Biological Chemistry, 2021
- Role of the TRPM4 channel in mitochondrial function, calcium release, and ROS generation in oxidative stressBiochemical and Biophysical Research Communications, 2021
- Mitochondrial ROS in myocardial ischemia reperfusion and remodelingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levelsBiochemical and Biophysical Research Communications, 2019
- Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion InjuryJACC, 2019